Utah § 58-17b-625 Administration of a long-acting injectable and naloxone.

Utah Statutes

§ 58-17b-625 — Administration of a long-acting injectable and naloxone.

Utah § 58-17b-625

Title 58Occupations and Professions

Ch. 58-17bPharmacy Practice Act

Part 58-17b-6Regulation of the Practice of Pharmacy Operating Standards

This text of Utah § 58-17b-625 (Administration of a long-acting injectable and naloxone.) is published on Counsel Stack Legal Research, covering Utah primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Utah Code Ann. § 58-17b-625 (2026).

Text

(1)A pharmacist may, in accordance with this section, administer a drug described in Subsection (2).

(2)Notwithstanding the provisions of Subsection 58-17b-102(58)(c)(ii)(B), the division shall make rules in collaboration with the board and, when appropriate, the Medical Licensing Board created in Section 58-67-201, and in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, to establish training for a pharmacist to administer naloxone and long-acting injectables intramuscularly.

(3)A pharmacist may not administer naloxone or a long-acting injectable intramuscularly unless the pharmacist:

(3)(a) completes the training described in Subsection (2);

(3)(b) administers the drug at a clinic or community pharmacy, as those terms are defined by the division, by administrat

Free access — add to your briefcase to read the full text and ask questions with AI

(1) A pharmacist may, in accordance with this section, administer a drug described in Subsection (2).
(2) Notwithstanding the provisions of Subsection 58-17b-102(58)(c)(ii)(B), the division shall make rules in collaboration with the board and, when appropriate, the Medical Licensing Board created in Section 58-67-201, and in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, to establish training for a pharmacist to administer naloxone and long-acting injectables intramuscularly.
(3) A pharmacist may not administer naloxone or a long-acting injectable intramuscularly unless the pharmacist:
(3)(a) completes the training described in Subsection (2);
(3)(b) administers the drug at a clinic or community pharmacy, as those terms are defined by the division, by administrative rule made in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act; and
(3)(c) is directed by the physician, as that term is defined in Section 58-67-102 or Section 58-68-102, who issues the prescription to administer the drug.